| Dec'19 | Sep'18 | Sep'17 | Sep'16 | |||
|---|---|---|---|---|---|---|
Revenues | ||||||
Total revenues | ||||||
311,332 | 12,737 | 8,629 | 12,730 | |||
Operating expenses | ||||||
Cost of product sales | ||||||
27,199 | 5,986 | 4,521 | 3,820 | |||
Research and development | ||||||
142,678 | 153,736 | 112,249 | 104,375 | |||
Selling, general and administrative | ||||||
259,880 | 141,818 | 58,020 | 33,188 | |||
Total operating expenses | ||||||
429,757 | 301,540 | 174,790 | 141,383 | |||
Loss from operations | ||||||
-118,425 | -288,803 | -166,161 | -128,653 | |||
Interest income | ||||||
8,464 | 3,645 | 2,063 | 611 | |||
Interest expense | ||||||
1,087 | 1,249 | 951 | 244 | |||
Other income | ||||||
104,117 | 0 | 0 | - | |||
Foreign exchange loss | ||||||
-2,272 | -4,963 | -6,442 | 35,897 | |||
Loss before income taxes | ||||||
-9,203 | -291,370 | -171,491 | -92,389 | |||
Income tax expense (benefit) | ||||||
-184 | 3,797 | -1,032 | -693 | |||
Net loss | ||||||
-9,019 | -295,167 | -170,459 | -91,696 | |||
Weighted average shares outstanding: | ||||||
Net loss per common share, basic and diluted | ||||||
-0.02 | -0.88 | -0.56 | -0.34 | |||
Weighted average common shares outstanding, basic and diluted | ||||||
371,580 | 333,936 | 305,826 | 272,165 | |||
Product Net Sales | ||||||
Total revenues | ||||||
310,331 | 10,469 | 7,957 | 7,317 | |||
Other Revenue | ||||||
Total revenues | ||||||
1,001 | 2,268 | 672 | 5,413 | |||